BioNexus Gene Lab Corp (BGLC): Market Cap to Revenue Ratio
The biochemistry sector is constrained by the aggressive pricing power of major Southeast Asian wholesalers; however, BioNexus Gene Lab Corp. is successfully expanding its network of molecular centers featuring unique genetic tests. Stable demand for early cancer diagnostics renders the business crisis-resistant, while the P/S trajectory illustrates the adequacy of the company's market valuation, and 0.70 determines the current value of this metric.
Metric breakdowns and analytics for BioNexus Gene Lab Corp. (BGLC)
- current quotes and average value forecast:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Capital BioNexus Gene Lab Corp.|BGLC - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient bionexusgenelab.com|BGLC - Company Total Debt|Debt to Net Assets Ratio BioNexus Gene Lab Corporation|BGLC - Company Long-Term Debts|Short-Term Indebtedness BioNexus Gene Lab|Immediate Liquidity bionexusgenelab.com
- earnings and multiples data:
BGLC - Company Net Income|Net Profit Forecast BioNexus Gene Lab Corp.|BGLC - P/E Multiple|Projected Price to Earnings Ratio bionexusgenelab.com|BGLC - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation BioNexus Gene Lab Corporation|BGLC - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months BioNexus Gene Lab|BGLC - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth bionexusgenelab.com|BGLC - Earnings growth in current year|Net earnings per share growth forecast for next year BioNexus Gene Lab Corp.
- sales revenue and business income indicators:
Summary company analytics:BioNexus Gene Lab Corp, BGLC
BioNexus Gene Lab Corp. is scaling the implementation of high-precision genetic tests for early oncology detection in Southeast Asia. The price-to-sales ratio reflects the current market valuation of every dollar of revenue generated by the company. This coefficient is calculated as the ratio of market capitalization to annual turnover, identifying either an overvaluation of the asset or a decline in sales margins. The stability of this metric confirms investor confidence in the effectiveness of the personalized therapy strategy.
Competing companies
LIN - Price to Sales|Price-to-Revenue Ratio Air Products and Chemicals APD|DD: Market Cap to Revenue Ratio|International Paper Corp - P/S Multiple|Price to Sales PPG Industries, Inc.|DOW (Dow Inc.) - Market Cap to Revenue|Market Cap to Revenue Ratio LYB|Market Cap to Revenue IFF|P/S Multiple RPM International Inc|Price-to-Revenue Ratio Entegris Corp (ENTG)|Price-to-Revenue Coefficient Suzano Group|Westlake Corporation - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio ALB|ICL Group - P/S Multiple|Price-to-Revenue Multiple NewMarket Corp (NEU)|EMN: P/S Multiple|Price to Sales Axalta Corp (AXTA)|Price-to-Revenue Ratio Element Solutions Inc|Market Cap to Revenue Ratio SQM (sqm.com)|P/S Multiple CE|SXT - Price to Sales|Cabot Microelectronics - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio HWKN|AVNT - Price-to-Revenue Ratio|FUL: Price-to-Revenue Ratio|MEOH: P/S Multiple|WD-40 Co. (WDFC) - P/S Multiple|CC (Chemours Corp) - P/S Multiple|Price-to-Revenue Ratio KWR|Market Cap to Revenue PCT (PureCycle Technologies)|ASH (ashland.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple NGVT (Ingevity)|IOSP - Market Cap to Revenue|MTX - Price-to-Revenue Ratio|Price to Sales Daqo Solar|Sylvamo Corporation (SLVM) - Price-to-Revenue Ratio|huntsman.com - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Albany International Corp.|Calumet Specialty Products Partners, L.P. - Price-to-Sales Ratio|Market Cap to Revenue ROG (Rogers Advanced Electronics)|Price-to-Revenue Coefficient Stepan Chemical|P/S Multiple ECVT (Ecovyst Inc.)|neogenomics.com - Price-to-Revenue Ratio|REX American Resources Corporation - P/S Multiple|Price-to-Revenue Multiple ASP Isotopes Inc (ASPI)|Tronox Limited (TROX) - Price-to-Revenue Ratio|GSM (Ferroglobe Group) - Price-to-Revenue Ratio|WLKP (Westlake Chemical Partners) - P/S Multiple|Market Cap to Revenue compassminerals.com (CMP)|P/S Multiple KRO|Market Cap to Revenue Mativ Holdings Inc MATV|P/S Multiple LXU (LSB Corp)|Market Capitalization-to-Revenue Ratio BAK|Koppers Holdings Inc. - P/S Multiple|Price to Sales advansix.com|Orion (OEC) - Price-to-Revenue Ratio|Market Cap to Revenue Rayonier Advanced Materials Inc.|ADUR (Aduro Corp) - P/S Multiple|Magnera Group (MAGN) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Clearwater Paper (CLW)|Price-to-Revenue Coefficient tredegar.com|Core Molding Technologies, Inc. - Market Cap to Revenue|Market Cap to Sales Volume FF (FutureFuel Corp)|FSI - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio ALTO (Alto Ingredients, Inc.)|FEAM (5eadvancedmaterials.com) - Market Cap to Revenue|Price to Sales Trinseo (TSE)|ORGN (Origin Materials Inc) - P/S Multiple|Price-to-Revenue Ratio NTIC|P/S Multiple LNZA|Price-to-Revenue Coefficient ymaunivers.com|Price-to-Revenue Ratio New Era Helium NUAI|boltthreads.com (BSLK) - Price to Sales|GURE - Price-to-Revenue Ratio|CNEY (CN Energy Group. Inc.) - Market Cap to Revenue Ratio|ALTM: P/S Multiple|Price to Sales Danimer Scientific, Inc (DNMR)|Market Cap to Revenue GLT|Market Cap to Revenue Ratio GRFX (Graphex)|Market Cap to Revenue SLCA (U.S. Silica)|P/S Multiple Invizyne Technologies Inc (IZTC)
